# 2026-16712: FDA Seeks Input on Import Entry Paperwork Burden

2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-08-17, effective Either electronic or written comments on the collection of information must be submitted by October 16, 2026.; PRIA reads it as touching household money (as of 2026-08-24).

- Canonical: https://policyrisk.com/federal-register/2026-16712
- As of: 2026-08-24
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-16712
- Title: Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 53259
- Published: 2026-08-17
- Effective: Either electronic or written comments on the collection of information must be submitted by October 16, 2026.
- Comments close: 2026-10-16
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-08-24

## In one line

FDA Seeks Input on Import Entry Paperwork Burden

## Summary

The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.

## Abstract

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public comment on the proposed collection of information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collections associated with our imports program.

## Effects PRIA read

- Mandatory Import Data Submissions: cost, high. If you import or offer for import FDA-regulated products into the United States, you must submit required data elements for all imported products when filing entries (per 21 CFR part 1, subparts D and E). The collection supports submission through CBP's Automated Commercial Environment (ACE) or any…
- Weekly Entry Filing (WEF) Option for FTZs: benefit, low. If you remove FDA-regulated merchandise from a Foreign Trade Zone (FTZ) for U.S. consumption, you may use the Weekly Entry Filing (WEF) program to file a single weekly entry estimating removals over a 7-day period. FDA recommends requesting a preliminary assessment and submitting specific data elem…
- ITACS Electronic Status and Submission Tool: benefit, low. Importers and entry filers can use FDA's Import Trade Auxiliary Communication System (ITACS) to create an account, check entry status, submit entry documentation, report goods' availability location for lines targeted for examination, and check estimated laboratory analysis completion dates. The no…
- Use of Specific FDA Import Forms (766 & 5054): cost, low. The information collection includes use of Form FDA 766 (Application for Authorization to Relabel or Recondition Non-compliant Articles) and electronic Form FDA 5054 (New Inquiry Form--Import Compliance Branch). The notice estimates 324 uses of Form FDA 766 at 0.25 hours each (81 hours) and 1,000 u…
- Formalized PLAIR Submission Process for Pre-Launch Imports: cost, medium. FDA's Pre-Launch Activities Importation Requests (PLAIR) guidance formalizes how applicants with pending new drug, abbreviated new drug, or CDER-regulated biologics licensing applications should request to import unapproved finished dosage forms for market launch preparation; PLAIR submissions shou…
- Large Aggregate Reporting Burden: cost, high. FDA estimates the total annual reporting burden for this collection as 2,077,245 hours across all respondents and responses. The docket requests comments on burden, utility, and ways to reduce the burden under the Paperwork Reduction Act.
- Public Comment Deadline for Import Collection: mixed, low. FDA is soliciting public comments on this information collection under the Paperwork Reduction Act, and comments must be submitted (electronically or in writing) by October 16, 2026. The notice asks for input on necessity, burden estimates, clarity, and ways to minimize burden.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-16712 on federalregister.gov](https://www.federalregister.gov/documents/2026/08/17/2026-16712/agency-information-collection-activities-proposed-collection-comment-request-imports-and-electronic)
- [2026-16712 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-08-17/pdf/2026-16712.pdf)

## Related
- [Previous: 2026-16711, Type VII Veterinary Master File for Research and Development and Risk Reviews;…](https://policyrisk.com/federal-register/2026-16711)
- [Next: 2026-16713, Determination of Regulatory Review Period for Purposes of Patent Extension; BIZ…](https://policyrisk.com/federal-register/2026-16713)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-16712 (as of 2026-08-24).
